252 related articles for article (PubMed ID: 2544829)
1. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R
Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829
[TBL] [Abstract][Full Text] [Related]
2. Intravenous methylprednisolone for multiple sclerosis in relapse.
Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ
J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids and multiple sclerosis.
Miller DH
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):290. PubMed ID: 9728938
[No Abstract] [Full Text] [Related]
4. Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
Liu S; Liu X; Chen S; Xiao Y; Zhuang W
PLoS One; 2017; 12(11):e0188644. PubMed ID: 29176905
[TBL] [Abstract][Full Text] [Related]
5. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
Tremlett HL; Luscombe DK; Wiles CM
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic indications for acute episodes of multiple sclerosis].
Brochet B
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):988-95. PubMed ID: 11787365
[TBL] [Abstract][Full Text] [Related]
7. "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.
Abbruzzese G; Gandolfo C; Loeb C
Ital J Neurol Sci; 1983 Jun; 4(2):169-72. PubMed ID: 6311774
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
Filippini G; Brusaferri F; Sibley WA; Citterio A; Ciucci G; Midgard R; Candelise L
Cochrane Database Syst Rev; 2000; (4):CD001331. PubMed ID: 11034713
[TBL] [Abstract][Full Text] [Related]
9. Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.
Simsarian JP; Saunders C; Smith DM
Drug Des Devel Ther; 2011; 5():381-9. PubMed ID: 21792296
[TBL] [Abstract][Full Text] [Related]
10. [Steroid therapy for multiple sclerosis].
Oishi C; Sakuta M
Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
[TBL] [Abstract][Full Text] [Related]
11. Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.
Dowling PC; Bosch VV; Cook SD
Neurology; 1980 Jul; 30(7 Pt 2):33-6. PubMed ID: 6248819
[TBL] [Abstract][Full Text] [Related]
12. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results.
Milanese C; La Mantia L; Salmaggi A; Campi A; Eoli M; Scaioli V; Nespolo A; Corridori F
Eur Neurol; 1989; 29(1):10-4. PubMed ID: 2540005
[TBL] [Abstract][Full Text] [Related]
13. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
[TBL] [Abstract][Full Text] [Related]
16. Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.
Stefoski D; Davis FA; Schauf CL
Ann Neurol; 1985 Oct; 18(4):443-50. PubMed ID: 3000278
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.
Alam SM; Kyriakides T; Lawden M; Newman PK
J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1219-20. PubMed ID: 8229035
[TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
19. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
Martinelli V; Rocca MA; Annovazzi P; Pulizzi A; Rodegher M; Martinelli Boneschi F; Scotti R; Falini A; Sormani MP; Comi G; Filippi M
Neurology; 2009 Dec; 73(22):1842-8. PubMed ID: 19949030
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of multiple sclerosis with Lyoproper].
Aschoff JC; Conrad B
Med Klin; 1971 Jun; 66(30):1055-8. PubMed ID: 4328079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
